MEI Pharma Announces $75 Million Private Placement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
MEI Pharma (MEIP) PT Lowered to $4.50 at Oppenheimer
May 15, 2018 7:26 AM EDTOppenheimer lowered its price target on MEI Pharma (NASDAQ: MEIP) to $4.50 (from $6.50) while maintaining an Outperform rating.
Analyst Leah Rush Cann commented, "We have expected that ME-401 will advance from phase Ib to a phase III study or a registration... More
